首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1169109

舍曲林盐酸盐市场：按类型、按应用、按分销渠道、按地区 - 规模、份额、展望、机会分析，2022-2030 年

Sertraline HCl Market, by Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年11月16日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格

简介目录

盐酸舍曲林属于一组称为选择性 5-羟色胺再摄取抑製剂 (SSRI) 的抗抑郁药。盐酸舍曲林与其他 SSRI 具有相同的作用机制。它通过增加大脑中可用的血清素的量来起作用。血清素是一种神经递质或化学信使，参与调节人日常生活的许多方面，包括情绪、睡眠、奖赏、学习和记忆。研究已将抑郁症与血清素水平低联繫起来。舍曲林增加大脑中血清素的含量，有助于扭转化学失衡并改善人们的整体情绪。舍曲林可作为口服片剂或液体使用。一般来说，每天早上或晚上服用一次。那些用于治疗经前烦躁症的可以每天服用或仅在每月的某些日子服用。

市场动态

主要市场趋势包括抗抑郁药处方率和支出的增加，预计这将在预测期内推动市场增长。例如，根据 Springer Nature Switzerland AG 于 2021 年 3 月发表的一篇文章，在 COVID-19 流行期间（2020 年 1 月至 12 月）分发的 Ads（抗抑郁药）处方总数为 7800 万，比 2020 年多 400 万2019 年，英国公共资助的医疗保健系统国民医疗服务体系 (NHS) 比 2019 年增加了 1.39 亿英镑（约合 1.707 亿美元）。 2020 年仅 SSRI 抗抑郁药舍曲林就比 2019 年增加了 1.13 亿英镑（1.387 亿美元）。

本研究的主要特点

本报告对全球盐酸舍曲林市场进行了深入分析，显示了以 2021 年为基准年的预测期（2022-2030 年）的市场规模（百万美元）和復合年增长率 (CAGR%) . 它提供。
解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
它根据以下参数介绍了全球盐酸舍曲林市场的主要参与者 - 公司概况、产品组合、主要亮点、财务业绩和战略。
本研究涵盖的主要公司包括辉瑞公司、Teva Pharmaceutical Industries Ltd.、Novartis AG、Accord Biopharma、Apotex Inc.、Aurobindo Pharma USA、InvaGen、Lupin、Camber Pharmaceuticals、Mylan（Viatris Inc 的一部分） .), Sun Pharmaceutical, Wockhardt, Alpic Biotech
这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
本报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以通过用于分析全球盐酸舍曲林市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

调查目的
先决条件
缩写说明

第二章市场展望

报告内容
- 市场定义和范围
执行摘要
- 市场概况：按类型分类
- 市场概况：按应用分类
- 市场概况：按分销渠道
- 市场概况：按地区
连贯机会图 (COM)

第3章市场动态、规律及趋势分析

市场动态
- 司机
- 约束因素
- 商机
影响分析
监管场景
市场趋势
主要发展状况
流行病学
害虫分析
合作伙伴关係和收购
搬运工分析
管道分析

第 4 章盐酸舍曲林全球市场 - 冠状病毒 (COVID-19) 大流行的影响

经济影响
对供需的影响
COVID-19 影响评估

第 5 章全球盐酸舍曲林市场类型，2017-2030

25毫克
50 毫克
100 毫克
其他

第 6 章。2017-2030 年全球盐酸舍曲林市场应用情况

强迫症
抑郁症
恐慌症
经前烦躁症
其他

第 7 章。全球盐酸舍曲林市场：按分销渠道，2017-2030

医院药房
零售药房
在线药店

第 8 章 2017-2030 年全球各地区盐酸舍曲林市场

北美
美国
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地区
欧洲
英国
德国
法国
意大利
西班牙
俄罗斯
其他欧洲
亚太地区
中国
印度
日本
澳大利亚
韩国
东盟
其他亚太地区
中东
海湾合作委员会
以色列
其他中东地区
非洲
北非
中非
南非

第9章竞争格局

热图分析
市场份额分析
- Pfizer
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Accord Biopharma
- Apotex Inc.
- Aurobindo Pharma USA
- InvaGen
- Lupin
- Camber Pharmaceuticals
- Mylan N.V.（a part of Viatris Inc.）
- Sun Pharmaceutical
- Wockhardt
- Alpic Biotech

第 10 章

调查方法介绍
关于出版商

简介目录

Product Code: CMI5355

Sertraline HCl belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Sertraline HCl has the same mechanism of action as other SSRIs. It works by increasing the amount of serotonin that is available in the brain. Serotonin is a neurotransmitter, or chemical messenger, that is involved in regulating many elements of a person's daily life, including mood, sleep, rewards, learning, and memory. Research has linked depression with low levels of serotonin. Sertraline increases the amount of serotonin present in the brain, helping to reduce chemical imbalances and improve a person's overall mood. Sertraline is available as either an oral tablet or a liquid. Typically, a person takes a dose in the morning or evening, once a day. People using it to treat premenstrual dysphoric disorder may take it every day or only on select days of the month.

Market Dynamics

Key trends in the market include increasing prescription rate and expenditure for antidepressant drug which is expected to drive the market growth during the forecast period. For instance, according to an article published in Springer Nature Switzerland AG in March 2021, stated that the total number of Ads (antidepressants) prescriptions dispensed during COVID-19 pandemic (January to December 2020) were 78 million, 4 million more than in 2019 that costed the National Health Service (NHS) is the publicly funded healthcare system in England, £139 million (US $170.7 million) more than in 2019. Sertraline, an SSRI antidepressant drug, alone accounted for an extra £113 million (US $ 138.7 million) during 2020 than in 2019.

Key features of the study:

This report provides an in-depth analysis of the global sertraline HCl market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sertraline HCl market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Accord Biopharma, Apotex Inc., Aurobindo Pharma USA, InvaGen, Lupin, Camber Pharmaceuticals, Mylan (a part of Viatris Inc.), Sun Pharmaceutical, Wockhardt, Alpic Biotech
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sertraline HCl market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sertraline HCl market.

Detailed Segmentation:

Global Sertraline HCl Market, By Type:
- 25 mg
- 50 mg
- 100 mg
- Others
Global Sertraline HCl Market, By Application:
- Obsessive-Compulsive Disorder
- Depression
- Panic Disorder
- Premenstrual Dysphoric Disorder
- Others
Global Sertraline HCl Market, By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Sertraline HCl Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Pfizer Inc *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.,
- Novartis AG
- Accord Biopharma
- Apotex Inc.,
- Aurobindo Pharma USA
- InvaGen
- Lupin
- Camber Pharmaceuticals
- Mylan N.V. (a part of Viatris Inc.)
- Sun Pharmaceutical
- Wockhardt
- Alpic Biotech

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Regulatory Scenario
Market Trends
Key Developments
Epidemiology
PEST Analysis
Collaboration and Acquisition
Porters Analysis
Pipeline Analysis

4. Global Sertraline HCl Market- Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
Impact on Demand and Supply
COVID-19 Impact Assessments

5. Global Sertraline HCl Market, By Type, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
25 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
100 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Sertraline HCl Market, By Application, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Obsessive-Compulsive Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Panic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Premenstrual Dysphoric Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Sertraline HCl Market, By Distribution channel, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Sertraline HCl Market, By Region, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn)
North Africa
Central Africa
South Africa